212 related articles for article (PubMed ID: 37047547)
41. The Role of Nicotinic Receptors in the Attenuation of Autism-Related Behaviors in a Murine BTBR T + tf/J Autistic Model.
Mahmood HM; Aldhalaan HM; Alshammari TK; Alqasem MA; Alshammari MA; Albekairi NA; AlSharari SD
Autism Res; 2020 Aug; 13(8):1311-1334. PubMed ID: 32691528
[TBL] [Abstract][Full Text] [Related]
42. Systemic inflammation in asocial BTBR T
Nadeem A; Ahmad SF; El-Sherbeeny AM; Al-Harbi NO; Bakheet SA; Attia SM
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():8-17. PubMed ID: 29287831
[TBL] [Abstract][Full Text] [Related]
43. The immunomodulatory effects of TNF-α inhibitors on human Th17 cells via RORγt histone acetylation.
Lin YC; Lin YC; Wu CC; Huang MY; Tsai WC; Hung CH; Kuo PL
Oncotarget; 2017 Jan; 8(5):7559-7571. PubMed ID: 27926504
[TBL] [Abstract][Full Text] [Related]
44. Genetic modifications associated with ketogenic diet treatment in the BTBR
Mychasiuk R; Rho JM
Autism Res; 2017 Mar; 10(3):456-471. PubMed ID: 27529337
[TBL] [Abstract][Full Text] [Related]
45. Implication of the social function of excessive self-grooming behavior in BTBR T
Arakawa H
Physiol Behav; 2021 Aug; 237():113432. PubMed ID: 33901528
[TBL] [Abstract][Full Text] [Related]
46. Cathepsin B inhibitor alleviates Th1, Th17, and Th22 transcription factor signaling dysregulation in experimental autoimmune encephalomyelitis.
Ansari MA; Nadeem A; Alshammari MA; Attia SM; Bakheet SA; Khan MR; Albekairi TH; Alasmari AF; Alhosaini K; Alqahtani F; Al-Mazroua HA; Ahmad SF
Exp Neurol; 2022 May; 351():113997. PubMed ID: 35122866
[TBL] [Abstract][Full Text] [Related]
47. Effects of the Partial M1 Muscarinic Cholinergic Receptor Agonist CDD-0102A on Stereotyped Motor Behaviors and Reversal Learning in the BTBR Mouse Model of Autism.
Athnaiel O; Job GA; Ocampo R; Teneqexhi P; Messer WS; Ragozzino ME
Int J Neuropsychopharmacol; 2022 Jan; 25(1):64-74. PubMed ID: 34791301
[TBL] [Abstract][Full Text] [Related]
48. Environmental enrichment improves metabolic and behavioral health in the BTBR mouse model of autism.
Queen NJ; Boardman AA; Patel RS; Siu JJ; Mo X; Cao L
Psychoneuroendocrinology; 2020 Jan; 111():104476. PubMed ID: 31648110
[TBL] [Abstract][Full Text] [Related]
49. Aflatoxin B
Almanaa TN; Alwetaid MY; Bakheet SA; Attia SM; Ansari MA; Nadeem A; Ahmad SF
J Neuroimmunol; 2024 Jun; 391():578365. PubMed ID: 38723577
[TBL] [Abstract][Full Text] [Related]
50. Low stress reactivity and neuroendocrine factors in the BTBR T+tf/J mouse model of autism.
Silverman JL; Yang M; Turner SM; Katz AM; Bell DB; Koenig JI; Crawley JN
Neuroscience; 2010 Dec; 171(4):1197-208. PubMed ID: 20888890
[TBL] [Abstract][Full Text] [Related]
51. Resveratrol Improves Neuroimmune Dysregulation Through the Inhibition of Neuronal Toll-Like Receptors and COX-2 Signaling in BTBR T
Ahmad SF; Ansari MA; Nadeem A; Alzahrani MZ; Bakheet SA; Attia SM
Neuromolecular Med; 2018 Mar; 20(1):133-146. PubMed ID: 29468499
[TBL] [Abstract][Full Text] [Related]
52. Ketogenic diet ameliorates autism spectrum disorders-like behaviors via reduced inflammatory factors and microbiota remodeling in BTBR T
Olivito I; Avolio E; Minervini D; Soda T; Rocca C; Angelone T; Iaquinta FS; Bellizzi D; De Rango F; Bruno R; De Bartolo L; Alò R; Canonaco M; Facciolo RM
Exp Neurol; 2023 Aug; 366():114432. PubMed ID: 37149279
[TBL] [Abstract][Full Text] [Related]
53. Effect of metformin in autistic BTBR T + Itpr3tf/J mice administered a high-fat diet.
Deng W; Li F; Ke H; Wang S; Li Z; Lv P; Chen Y
Brain Res Bull; 2022 Jun; 183():172-183. PubMed ID: 35240246
[TBL] [Abstract][Full Text] [Related]
54. Inbred strain preference in the BTBR T
Ryan K; Thompson L; Mendoza PA; Chadman KK
Autism Res; 2019 Aug; 12(8):1184-1191. PubMed ID: 31206258
[TBL] [Abstract][Full Text] [Related]
55. The adenosine A
Amodeo DA; Cuevas L; Dunn JT; Sweeney JA; Ragozzino ME
Autism Res; 2018 Feb; 11(2):223-233. PubMed ID: 29193861
[TBL] [Abstract][Full Text] [Related]
56. Differential Expression of Hippocampal Circular RNAs in the BTBR Mouse Model for Autism Spectrum Disorder.
Gasparini S; Del Vecchio G; Gioiosa S; Flati T; Castrignano T; Legnini I; Licursi V; Ricceri L; Scattoni ML; Rinaldi A; Presutti C; Mannironi C
Mol Neurobiol; 2020 May; 57(5):2301-2313. PubMed ID: 32020500
[TBL] [Abstract][Full Text] [Related]
57. Toll-like receptors, NF-κB, and IL-27 mediate adenosine A2A receptor signaling in BTBR T
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Ayadhi LY; Attia SM
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):184-191. PubMed ID: 28668513
[TBL] [Abstract][Full Text] [Related]
58.
Park HY; Go J; Ryu YK; Choi DH; Noh JR; An JP; Oh WK; Han PL; Lee CH; Kim KS
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880583
[No Abstract] [Full Text] [Related]
59. Epothilone D Modulates Autism-like Behaviors in the BTBR Mouse Model of Autism Spectrum Disorder.
Zhao M; Chang Q; Yang H; Wang M; Liu Y; Lv N; Lei Q; Wei H
Neuroscience; 2022 May; 490():171-181. PubMed ID: 35227832
[TBL] [Abstract][Full Text] [Related]
60. Altered meningeal immunity contributing to the autism-like behavior of BTBR
Uddin MN; Manley K; Lawrence DA
Brain Behav Immun Health; 2022 Dec; 26():100563. PubMed ID: 36439055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]